Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies.
about
Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Formulation, Development, and ...... cline for B Cell Malignancies.
@en
Formulation, Development, and ...... cline for B Cell Malignancies.
@nl
type
label
Formulation, Development, and ...... cline for B Cell Malignancies.
@en
Formulation, Development, and ...... cline for B Cell Malignancies.
@nl
prefLabel
Formulation, Development, and ...... cline for B Cell Malignancies.
@en
Formulation, Development, and ...... cline for B Cell Malignancies.
@nl
P2093
P2860
P1433
P1476
Formulation, Development, and ...... cline for B Cell Malignancies.
@en
P2093
Bivash Mandal
Dileep R Janagam
George C Wood
Laura A Thoma
Leonard Lothstein
Pavan Balabathula
Saini Setua
P2860
P356
10.3390/PHARMACEUTICS10020050
P577
2018-04-15T00:00:00Z